{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T16:18:28Z","timestamp":1720628308875},"reference-count":39,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3205,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.01212.x","type":"journal-article","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T11:04:39Z","timestamp":1164193479000},"page":"27-32","source":"Crossref","is-referenced-by-count":5,"special_numbering":"supplement s151","title":["The emerging role of intravesical botulinum toxin therapy in idiopathic detrusor overactivity"],"prefix":"10.1155","volume":"60","author":[{"given":"A. K.","family":"PATEL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"PATTERSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. R.","family":"CHAPPLE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,11,22]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int"},{"issue":"Suppl. 11","key":"10.1111\/j.1742-1241.2006.01212.x-BIB2|cit2","first-page":"S565","article-title":"The prevalence of overactive bladder","volume":"6","author":"Milsom","year":"2000","journal-title":"Am J Manag Care"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"issue":"Suppl. 2","key":"10.1111\/j.1742-1241.2006.01212.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.urology.2006.05.043","article-title":"The effects of antimuscarinics on health-related quality of life in overactive bladder: a systematic review and meta-analysis","volume":"68","author":"Khullar","year":"2006","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/jwh.2006.15.251","article-title":"The causes and consequences of overactive bladder","volume":"15","author":"Miller","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00192-005-0032-3","article-title":"The puzzle of overactive bladder: controversies, inconsistencies, and insights","volume":"17","author":"Dmochowski","year":"2006","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients","volume":"139","author":"Dykstra","year":"1988","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","article-title":"Treatment of neurogenic incontinence with botulinum toxin A","volume":"2","author":"Schurch","year":"2000","journal-title":"N Engl J Med"},{"issue":"3 Pt 1","key":"10.1111\/j.1742-1241.2006.01212.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1569-9056(05)80563-9","article-title":"Experience of 100 cases treated with botulinum-A toxin injections into the detrusor muscle for overactive bladder refractory to anticholinergics","volume":"4","author":"Schmid","year":"2005","journal-title":"Eur Urol Suppl"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1569-9056(04)90513-1","article-title":"Botulinum toxin injections to treat overactive bladder","volume":"3","author":"Schmid","year":"2004","journal-title":"Eur Urol Suppl"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB12|cit12","first-page":"412","article-title":"Trigonum and bladder base injection of botulinum toxin A (BoNT) in patients with severe urgency-frequency syndrome refractory to conservative medical treatment and electrical stimulation","volume":"20","author":"Zermann","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB13|cit13","article-title":"Botulinum toxin-A for patients with idiopathic detrusor overactivity: early results from a randomised, double-blind, placebo-controlled trial","author":"Sahai","year":"2005","journal-title":"International Continence Society Annual Meeting"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB14|cit14","doi-asserted-by":"crossref","unstructured":"Gousse A Tunuguntla HSGR Rodriguez D et\u00a0al. Dose-Finding Prospective Randomized Study to evaluate the efficacy and safety of botulinum-A toxin for refractory idiopathic overactive bladder 2005","DOI":"10.1016\/S0022-5347(18)35280-7"},{"issue":"6 Pt 1","key":"10.1111\/j.1742-1241.2006.01212.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/01.ju.0000143889.00681.3f","article-title":"The effect of botulinum-A toxin on patients with severe urge urinary incontinence","volume":"172","author":"Flynn","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1569-9056(02)80519-X","article-title":"Botulinum toxin type A intravesical injections for intractable bladder overactivity","volume":"1","author":"Radziszewski","year":"2002","journal-title":"Eur Urol Suppl"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB17|cit17","first-page":"1216","article-title":"Intradetrusor injections of botulinum A toxin to treat severe detrusor overactivity","volume":"75","author":"Fowler","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.2003.04312.x","article-title":"A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity","volume":"92","author":"Harper","year":"2003","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2006.07.022","article-title":"Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results","volume":"50","author":"Patel","year":"2006","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB20|cit20","doi-asserted-by":"crossref","unstructured":"Abdelmalak JB Rackley RR Vasavada SP et\u00a0al. Botulinum A toxin (Botox) injection for the treatment of refractory overactive bladder 2004","DOI":"10.1097\/01.spv.0000134144.13202.ed"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1464-410X.2005.05725.x","article-title":"A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity","volume":"96","author":"Rajkumar","year":"2005","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.eururo.2005.06.021","article-title":"Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction","volume":"48","author":"Schulte-Baukloh","year":"2005","journal-title":"Eur Urol"},{"issue":"Suppl. 4","key":"10.1111\/j.1742-1241.2006.01212.x-BIB23|cit23","first-page":"351","article-title":"Successful use of bladder botulinum toxin injection to treat refractory overactive bladder","volume":"169","author":"Chancellor","year":"2003","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2005.01.036","article-title":"Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","article-title":"Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study","volume":"192","author":"Werner","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB27|cit27","unstructured":"Sweeney D O'Leary M Erickson J et\u00a0al. Safety and efficacy with bladder botulinum toxin in elderly patients 2005"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB28|cit28","unstructured":"Hoebeke P Decaestecker K Verleyen P et al Extended experience with the use of botulinum toxin A in children with non neurogenic voiding dysfunction ESPU-AAP Joint Conference 2005"},{"issue":"Suppl. 2","key":"10.1111\/j.1742-1241.2006.01212.x-BIB29|cit29","article-title":"The use of botulinum toxin A in children with a non-neurogenic overactive bladder: a pilot study","volume":"93","author":"Verleyen","year":"2004","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB30|cit30","unstructured":"Peeren F Everaert K Hoebeke P et\u00a0al. Successive injections of botulinum A toxin (Botox) in paediatric population 2005"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB31|cit31","unstructured":"Hirst G Wareham K Emery S et\u00a0al. Failure of botulinum toxin type B in the treatment of the refractory overactive bladder 2005"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a Randomized, Double-Blind, Placebo Controlled, Crossover Trial","volume":"174","author":"Ghei","year":"2005","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00192-003-1099-3","article-title":"Treatment of overactive bladder with botulinum toxin type B: a pilot study","volume":"14","author":"Dykstra","year":"2003","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB34|cit34","doi-asserted-by":"crossref","unstructured":"Kalsi V Popat R Odyemi I et\u00a0al. A cost effectiveness model for botulinum neurotoxin type A (BoNT\/A) in the treatment of patients with detrusor overactivity: preliminary results 2005","DOI":"10.1016\/S1569-9056(05)80414-2"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","article-title":"A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin","volume":"174","author":"Popat","year":"2005","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","article-title":"Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience","volume":"63","author":"Rapp","year":"2004","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB37|cit37","unstructured":"Keppenne V Gaspard Y Mathantu B et\u00a0al. Detrusor injection of botulinum A toxin for idiopathic overactive bladder syndrome: clinical and urodynamic evaluation 2005"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01212.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","article-title":"Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics","volume":"66","author":"Kuo","year":"2005","journal-title":"Urology"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.01212.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.01212.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T19:43:52Z","timestamp":1683661432000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.01212.x"}},"subtitle":["BOTULINUM TOXINS IN IDIOPATHIC DO"],"short-title":[],"issued":{"date-parts":[[2006,11,22]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01212.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11,22]]}}}